-
Editorial
July 31, 2025
- Editorial for JUO 2025 Vol. 23 No. 2 - Highlights of This Issue’s Papers and the JUO Editors’ Pick
- Cheol Kwak
- J Urol Oncol. 2025;23(2):95-97.
-
Original Article
July 31, 2025
- Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses
- Minyong Kang, ByulA Jee, Jiwoong Yu, et al.
- J Urol Oncol. 2025;23(2):98-111.
-
Original Article
July 31, 2025
- Decisional Trade-offs in Localized Prostate Cancer: A Prospective Cross-Sectional Study of Radical Prostatectomy, Radiation Therapy, and Active Surveillance
- Hyunho Han, Youngdeuk Choi, Woong Kyu Han, et al.
- J Urol Oncol. 2025;23(2):112-118.
-
Original Article
July 31, 2025
- A Prospective, Multicenter Study on the Clinical Effectiveness and Safety of Abiraterone Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer in Korea: Real-World Data Analysis
- Hyomyoung Lee, Seung-hwan Jeong, Sangeun Yeon, et al.
- J Urol Oncol. 2025;23(2):119-125.
-
Original Article
July 31, 2025
- Incidental Prostate Cancer in Radical Cystectomy: Insights From the Largest Korean Cohort to Date
- Young Hwii Ko, Jungmin Jo, Myung Soo Kim, et al.
- J Urol Oncol. 2025;23(2):126-131.
-
Original Article
July 31, 2025
- Expression and Prognostic Value of VEGF, VEGFR1, VEGFR2, VEGFR3, and E-Cadherin in Clear Cell Renal Cell Carcinoma
- Mónica Sanz del Pozo, Joaquín Gimeno Pelegrín, Nebay Rodríguez Muñoz, et al.
- J Urol Oncol. 2025;23(2):132-139.
-
Original Article
July 31, 2025
- Adverse Prognosis in Dialysis Patients Undergoing Systemic Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Study
- Shun Iwasa, Ryuichi Mizuno, Keishiro Fukumoto, et al.
- J Urol Oncol. 2025;23(2):140-147.
-
Original Article
July 31, 2025
- Factors Associated With Pericardial Effusion and Mortality in Renal Cancer Patients
- Kennedy E. Okhawere, Jewel Bamby, Indu Saini, et al.
- J Urol Oncol. 2025;23(2):148-163.
-
Review Article
July 31, 2025
- Smart Nanocarriers as an Emerging Platform in Urologic Cancer Immunotherapy: A Review on Clinical Insights and Applications
- Sania Hassan, Afshan Ayaz, Afaf Nawaz, et al.
- J Urol Oncol. 2025;23(2):164-187.
-
Original Article
July 31, 2025
- The Impact of Neoadjuvant Chemotherapy on Cancer Specific Mortality in Patients With Upper Tract Urothelial Carcinoma: A Retrospective Analysis of an Other Cause Mortality Risk Matched Cohort
- Alessandro Bertini, Alex Stephens, Alessio Finocchiaro, et al.
- J Urol Oncol. 2025;23(2):188-197.
-
Original Article
July 31, 2025
- The Value of Magnetic Resonance Imaging-Driven Apparent Diffusion Coefficient to Predict Pathologic Response of Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Study
- Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, et al.
- J Urol Oncol. 2025;23(2):198-206.
-
Letter to the Editor
July 31, 2025
- Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Prostate Cancer Treatment?
- Momina Ahmed, Maheen Shaharyar, Amna Binte Naeem
- J Urol Oncol. 2025;23(2):207-208.
-
Editorial Commentary
July 31, 2025
- Editorial Commentary on Letter “Glucagon-Like Peptide-1 Receptor Agonists: A New Frontier in Prostate Cancer Treatment?”
- Young Hwii Ko
- J Urol Oncol. 2025;23(2):209-210.
-
-
Journal of
Urologic OncologyPrint ISSN: 2951-603X
Online ISSN: 2982-7043
- Editorial Office
-
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.orgKorean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac
Copyright © The Korean Urological Oncology Society.
